- Home
- KG vs AMRX Comparison
KG vs AMRX Comparison
Compare KG & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KG
- AMRX
- Stock Information
- Founded
- KG N/A
- AMRX 2002
- Country
- KG Bermuda
- AMRX United States
- Employees
- KG N/A
- AMRX N/A
- Industry
- KG Property-Casualty Insurers
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- KG Finance
- AMRX Health Care
- Exchange
- KG Nasdaq
- AMRX Nasdaq
- Market Cap
- KG 2.5B
- AMRX 2.3B
- IPO Year
- KG N/A
- AMRX N/A
- Fundamental
- Price
- KG N/A
- AMRX $7.49
- Analyst Decision
- KG
- AMRX Strong Buy
- Analyst Count
- KG 0
- AMRX 4
- Target Price
- KG N/A
- AMRX $11.50
- AVG Volume (30 Days)
- KG 33.9K
- AMRX 1.6M
- Earning Date
- KG 01-01-0001
- AMRX 05-02-2025
- Dividend Yield
- KG N/A
- AMRX N/A
- EPS Growth
- KG N/A
- AMRX N/A
- EPS
- KG N/A
- AMRX N/A
- Revenue
- KG N/A
- AMRX $2,830,186,000.00
- Revenue This Year
- KG N/A
- AMRX $10.20
- Revenue Next Year
- KG N/A
- AMRX $7.15
- P/E Ratio
- KG N/A
- AMRX N/A
- Revenue Growth
- KG N/A
- AMRX 13.42
- 52 Week Low
- KG $21.81
- AMRX $6.29
- 52 Week High
- KG $36.80
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- KG N/A
- AMRX 52.36
- Support Level
- KG N/A
- AMRX $7.02
- Resistance Level
- KG N/A
- AMRX $7.51
- Average True Range (ATR)
- KG 0.00
- AMRX 0.16
- MACD
- KG 0.00
- AMRX 0.03
- Stochastic Oscillator
- KG 0.00
- AMRX 78.05
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.